Contra-indicated in patients with persistent systolic blood pressure <100 mm Hg prior to therapy because of an increased risk of symptomatic hypotension.
- TRADE NAME: Natrecor (Scios)
- INDICATIONS: Acutely decompensated congestive heart failure
- CLASS: Hormone, polypeptide, Natriuretic, Vasodilator
- HALF-LIFE: 18 minutes
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Hypotensives
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
